Literature DB >> 25051917

Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.

Chun-Jiang Li1, Yue Dai, Yan-Jun Fu, Jia-Ming Tian, Jin-Lun Li, Hong-Jun Lu, Feng Duan, Qing-Wang Li.   

Abstract

The meta-analysis was conducted to evaluate the correlations between common genetic polymorphisms in the IFN-γ gene and susceptibility to breast cancer. The following electronic databases were searched without language restrictions: MEDLINE (1966 ~ 2013), the Cochrane Library Database (issue 12, 2013), EMBASE (1980 ~ 2013), CINAHL (1982 ~ 2013), Web of Science (1945 ~ 2013), and the Chinese Biomedical Database (CBM) (1982 ~ 2013). Meta-analysis was performed with the use of the STATA statistical software. Odds ratios (OR) with their 95 % confidence intervals (95 % CIs) were calculated. Nine clinical case-control studies met all the inclusion criteria and were included in this meta-analysis. A total of 1,182 breast cancer patients and 1,525 healthy controls were involved in this meta-analysis. Three functional polymorphisms were assessed, including rs2069705 C>T, rs2430561 T>A, and CA repeats 2/X. Our meta-analysis results indicated that IFN-γ genetic polymorphisms might be significantly associated with an increased risk of breast cancer (allele model: OR = 1.37, 95 % CI = 1.03 ~ 1.83, P = 0.031; dominant model: OR = 1.55, 95 % CI = 1.01 ~ 2.37, P = 0.046; homozygous model: OR = 2.23, 95 % CI = 1.30 ~ 3.82, P = 0.004; respectively), especially the rs2430561 T>A polymorphism. Subgroup analysis based on ethnicity suggested that genetic polymorphisms in the IFN-γ gene were closely correlated with increased breast cancer risk among Asians (allele model: OR = 1.21, 95 % CI = 1.02 ~ 1.58, P = 0.017; dominant model: OR = 3.44, 95 % CI = 2.07 ~ 5.71, P < 0.001; recessive model: OR = 1.58, 95 % CI = 1.06 ~ 2.37, P = 0.025; homozygous model: OR = 1.83, 95 % CI = 1.19 ~ 2.80, P = 0.006; respectively), but not among Caucasians (all P > 0.05). Our meta-analysis supported the hypothesis that IFN-γ genetic polymorphisms may contribute to an increased risk of breast cancer, especially the rs2430561 T>A polymorphism among Asians.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25051917     DOI: 10.1007/s13277-014-1856-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-γ on breast cancer risk.

Authors:  Jian-Rong He; Li-Juan Chen; Yi Su; Yu-Ling Cen; Lu-Ying Tang; Dan-Dan Yu; Wei-Qing Chen; Shen-Ming Wang; Er-Wei Song; Ze-Fang Ren
Journal:  J Infect Dis       Date:  2011-11-17       Impact factor: 5.226

Review 2.  Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Siamon Gordon
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

3.  Cigarette smoking and the incidence of breast cancer.

Authors:  Fei Xue; Walter C Willett; Bernard A Rosner; Susan E Hankinson; Karin B Michels
Journal:  Arch Intern Med       Date:  2011-01-24

4.  Decreased serum miR-181a is a potential new tool for breast cancer screening.

Authors:  Li-Juan Guo; Qing-Yun Zhang
Journal:  Int J Mol Med       Date:  2012-06-11       Impact factor: 4.101

5.  Development of a manual self-assembled colloidal gold nanoparticle-immunochromatographic strip for rapid determination of human interferon-γ.

Authors:  Shu-Fen Chou
Journal:  Analyst       Date:  2013-05-07       Impact factor: 4.616

6.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

7.  Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.

Authors:  Anne S Reiner; Esther M John; Jennifer D Brooks; Charles F Lynch; Leslie Bernstein; Lene Mellemkjær; Kathleen E Malone; Julia A Knight; Marinela Capanu; Sharon N Teraoka; Patrick Concannon; Xiaolin Liang; Jane C Figueiredo; Susan A Smith; Marilyn Stovall; Malcolm C Pike; Robert W Haile; Duncan C Thomas; Colin B Begg; Jonine L Bernstein
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

8.  Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database.

Authors:  Louise A Brinton; J Daniel Carreon; Gretchen L Gierach; Katherine A McGlynn; Gloria Gridley
Journal:  Breast Cancer Res Treat       Date:  2009-03-29       Impact factor: 4.872

9.  Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer.

Authors:  Christine Bouchardy; Elisabetta Rapiti; Gerald Fioretta; Hyma Schubert; Pierre Chappuis; Georges Vlastos; Simone Benhamou
Journal:  Swiss Med Wkly       Date:  2013-11-12       Impact factor: 2.193

10.  Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea.

Authors:  Sue K Park; Yeonju Kim; Daehee Kang; En-Joo Jung; Keun-Young Yoo
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

View more
  7 in total

Review 1.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

2.  Association between IFN-γ +874 T/A (Rs2430561) Polymorphisms and Bipolar 1 Disorder: A Study in an Ethnic Iranian Population.

Authors:  Mahdieh Fatemi Nayeri; Ali Talaei; Jalil Tavakkol Afshari; Amin Reza Nikpoor; Andisheh Talaei; Rashin Ganjali
Journal:  Rep Biochem Mol Biol       Date:  2019-04

Review 3.  Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-Analysis.

Authors:  Zhitong Wu; Yifan Sun; Shengbo Zhu; Shifu Tang; Chunming Liu; Wenzhou Qin
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

4.  Thrombocytopenia in solid tumors: Prognostic significance.

Authors:  Majid Ghanavat; Mina Ebrahimi; Hassan Rafieemehr; Mahmood Maniati; Masumeh Maleki Behzad; Saeid Shahrabi
Journal:  Oncol Rev       Date:  2019-05-14

5.  The IFN-Ɣ + 874 A/T polymorphism is associated with malignant breast cancer in a population from the southwest of Iran.

Authors:  Hadi Rezaeean; Gholam Abbas Kaydani; Najmaldin Saki; Sasan Razmjoo; Maryam Labibzadeh; Hamid Yaghooti
Journal:  BMC Res Notes       Date:  2021-04-20

6.  The MIF -173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test.

Authors:  Xiang Tong; Bing Zheng; Qiaoyi Tong; Sitong Liu; Sifeng Peng; Xin Yang; Hong Fan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.

Authors:  K Torres-Poveda; A I Burguete-García; M Bahena-Román; R Méndez-Martínez; M A Zurita-Díaz; G López-Estrada; K Delgado-Romero; O Peralta-Zaragoza; V H Bermúdez-Morales; D Cantú; A García-Carrancá; V Madrid-Marina
Journal:  BMC Cancer       Date:  2016-05-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.